June 2010 Volume 6, Issue 6

Volume 6, Issue 6 | June 2010

June 2010

In this Issue

Global News

Drug Discovery News Placeholder Image

Sticking together against Huntington’s

BioFocus and CHDI enter new five-year collaboration for Huntington’s disease therapeutics
Drug Discovery News Placeholder Image

A breath of fresh air

Novartis acquires Oriel Therapeutics, gains portfolio of respiratory products targeting asthma and COPD
Drug Discovery News Placeholder Image

Scientists working for scientists

Stemgent and Miltenyi Biotec agree to co-develop stem cell research products
Drug Discovery News Placeholder Image

Taking a BiTE out of multiple myeloma

Boehringer Ingelheim, Micromet announce global collaboration for multiple myeloma BiTE antibody
Drug Discovery News Placeholder Image

Eppendorf and Akonni to co-market extraction kits

Eppendorf North America and Akonni Biosystems have entered into a joint marketing agreement to promote Akonni TruTip nucleic acid extraction kits configured for use with Eppendorf epMotion automated pipetting systems.
Drug Discovery News Placeholder Image

Striking from two sides … or more

TB Alliance and AstraZeneca form research collaboration to fight tuberculosis

Diagnostics

Drug Discovery News Placeholder Image

On the right path for MDx growth

ExonHit acquires RedPath Integrated Pathology to create ‘molecular diagnostic powerhouse’
Drug Discovery News Placeholder Image

Promising diagnosis for success

As part of a strategic agreement, bioMérieux purchases $5 million equity stake in Knome
Drug Discovery News Placeholder Image

Clavis and Clovis take a companion

Clovis Oncology to develop and commercialize hENT1 companion diagnostic with Ventana Medical Systems
Drug Discovery News Placeholder Image

Licensed to test

Warnex Medical Laboratories obtains rights to establish Epigemomics’ laboratory-developed test for Septin9

Contract Services

Drug Discovery News Placeholder Image

Doxorubicin’s new clothes

SIOGEN and Veeda announce partnership to develop new nanoparticle formulation of Doxorubicin for cancer treatment
Drug Discovery News Placeholder Image

Expressing themselves

Aragen and CEVEC sign agreement covering novel human expression system
Drug Discovery News Placeholder Image

Fordham builds partnership for global healthcare innovation

ACRO funds Global Healthcare Innovation Management Center At Fordham University Schools of Business
Drug Discovery News Placeholder Image

A New York state of MSA

Agreement enables CLINiLABS to add ECG core lab services
Drug Discovery News Placeholder Image

DSM Biologics launches Australian biopharma manufacturing facility

DSM Biologics, a business unit of DSM Pharmaceutical Products, a global business providing cGMP custom manufacturing services across all facets of the pharmaceutical industry, has signed preliminary agreements with the Australian government to design, build and operate the first major Australia-based mammalian biopharmaceutical manufacturing facility, which will be located in Brisbane.
Drug Discovery News Placeholder Image

From molecule to market

Charles River Laboratories acquires WuXi PharmaTech for $1.6 billion, creating a CRO with services from early-stage drug development to clinical trials

Research & Development

Drug Discovery News Placeholder Image

No gain without pain

sanofi-aventis, Glenmark sign global agreement aimed at treating chronic pain
Drug Discovery News Placeholder Image

Combining immunomodulators with cancer vaccines

IRX Therapeutics announces cancer vaccine collaboration with Japan’s National Cancer Research Center
Drug Discovery News Placeholder Image

The better to see you with

EyeGate, GSK collaborate on ocular delivery of drugs
Drug Discovery News Placeholder Image

TNT for tumors

Peregrine grants Stason rights to develop TNT products in APEC countries
Drug Discovery News Placeholder Image

Biotech expertise to raise profile of neglected disease

Medicines for Malaria Venture and Anacor Pharmaceuticals collaborate on applying boron chemistry technology to treat malaria

Special Reports

Drug Discovery News Placeholder Image

CROs take advantage of M&A madness

The landscape has been changing drastically over the last year or so, with a string of mergers and acquisitions resulting in the formation of new collaborations, new companies and allegiances that have reshaped the market
Drug Discovery News Placeholder Image

Where are the jobs?

With companies cutting staff and outsourcing services, your job may be moving overseas; but then again, it may just be moving down the street

Commentary

Drug Discovery News Placeholder Image

Preanalytical sample handling protocols can advance personalized medicine and science

Basic research and industry adoption of standard protocols and tools for preanalytical sample handling are necessary to advance personalized medicine and science
Drug Discovery News Placeholder Image

What is ‘personalized medicine?’

Medicine remains an art to be practiced. Given that no two doctors and no two patients are the same in all respects, it has always been personalized

Editor's Focus

Drug Discovery News Placeholder Image

We are all witnesses … to failure and success

We must make better use of our time, energy and priorities, focusing not on negative outcomes, but asking the questions that will lead us to results we seek.

Instruments & Informatics

Drug Discovery News Placeholder Image

Back in the workflow

Freeslate announces software partnership with Johnson & Johnson Pharmaceutical Research & Development
Drug Discovery News Placeholder Image

Meeting mass spec challenges head-on

Samuel Lunenfeld Research Institute advances protein research with help from new AB SCIEX technology
Drug Discovery News Placeholder Image

Arrayed from end to end

BioDiscovery and Exiqon sign OEM agreement to provide complete miRNA analysis solution
Drug Discovery News Placeholder Image

Temperature- controlled Sample Storage

BioStorage will use Biomatrica’s RT storage technology to provide conversion services

Omics & Systems Biology

Drug Discovery News Placeholder Image

Going with the flow

Thermo Fisher Scientific acquires Proxeon, a proteomics workflow solution provider
Drug Discovery News Placeholder Image

Two are better than one

Duke, LabCorp combine forces to create The Biomarker Factory
Drug Discovery News Placeholder Image

HTG signs collaboration agreement with John Wayne Cancer Institute

Aim is to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using classical surgical pathology samples
Drug Discovery News Placeholder Image

Going boldly into the transcriptome

Ocimum partners with Jivan to provide sequencing-based transcriptome profiling services
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue